where can i get glp 1 meds GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Half of GLP-1 users ditch

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

What matters most though is what patients are experiencing are they able to reliably access their medication

GLP-1 agonists may: Optimize high-risk patients before surgery Improve metabolic control Potentially reduce surgical risk But durable long-term outcomes in severe obesity still rely heavily on: Surgical intervention Lifelong follow-up Nutritional monitoring Multidisciplinary care The future may not be medicine vs surgery. It may be the intelligent integration of both

Recent studies...

In this post, Ill share with you some of the plotline for our discussion